尿尿调节素降低可能与急性肾损伤相关:系统评价与Meta分析
本研究为系统评价与Meta分析,检索Medline、Web of Science、Cochrane Library、Embase及3个中文数据库至2021年2月,纳入11项研究共3148名受试者,评估尿尿调节素(uUMOD)与AKI的关联。结果显示AKI组uUMOD显著低于非AKI组(SMD -0.71,95%CI -1.00至-0.42,P<0.001,I²=78.8%),亚组分析在儿童(SMD -1.21)和手术患者(SMD -1.03)中差异显著,但急性排斥组不显著。较低的uUMOD与AKI发生风险升高相关(OR 2.47,95%CI 1.12至5.47,P<0.001,I²=89%)。Meta回归发现年龄与uUMOD的SMD相关,敏感性分析证实结果可靠。
要点
- AKI组尿尿调节素显著低于非AKI组:SMD -0.71(95%CI -1.00至-0.42,P<0.001),异质性I²=78.8%。
- 儿童亚组差异最显著:SMD -1.21(95%CI -1.80至-0.61,P<0.001);手术患者亚组SMD -1.03(95%CI -1.75至-0.30,P<0.001)。
- 急性排斥(AR)亚组uUMOD差异不显著。
- 较低的尿调节素与AKI发生风险升高相关:OR 2.47(95%CI 1.12至5.47,P<0.001),异质性I²=89%。
- Meta回归发现年龄与uUMOD的SMD相关;敏感性分析(留一法)证实结果可靠。
适用人群与场景
- 共纳入11项研究、3148名受试者,比较AKI与非AKI患者;亚组包括不同年龄、手术状态、检测时间及急性排斥(AR)组。
研究设计与关键结果
- 研究类型为系统评价与Meta分析,检索Medline、Web of Science、Cochrane Library、Embase及3个中文数据库自建库至2021年2月,无语言限制,采用随机效应模型。
- 共纳入11项研究、3148名受试者;AKI组尿尿调节素显著低于非AKI组,SMD -0.71(95%CI -1.00至-0.42,P<0.001,I²=78.8%)。
- 亚组分析显示不同年龄、手术状态和检测时间亚组差异均显著,但急性排斥(AR)组不显著;儿童亚组SMD -1.21(95%CI -1.80至-0.61,P<0.001),手术患者亚组SMD -1.03(95%CI -1.75至-0.30,P<0.001)。
- 较低的尿调节素与AKI发生风险升高相关:OR 2.47(95%CI 1.12至5.47,P<0.001,I²=89%)。
- Meta回归发现年龄与uUMOD的SMD相关;留一法敏感性分析证实结果可靠。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析(11项研究,3148名受试者)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为尿尿调节素与AKI呈负相关,尤其在儿童和手术患者中;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Urinary uromodulin (uUMOD) is one of the novel biomarkers for predicting AKI. However, currently available publications showed inconsistent results. We designed this meta-analysis to evaluate the potential association between uUMOD and AKI.
METHODS: We searched research articles with no language restriction in Medline, Web of Science, Cochrane Library, Embase, and 3 Chinese datasets from inception to February 2021. We used random-effects models to estimate the standardized mean difference (SMD) between patients with AKI or not, while the leave-one-out method and random-effects meta-regression to evaluate the sensitivity and the impact of potential confounders such as age and surgery.
RESULTS: The meta-analysis comprising 3148 subjects from 11 studies showed that the uUMOD of the AKI group is significantly lower than the non-AKI group (SMD: - 0.71; 95% confidence interval (CI), - 1.00, - 0.42, P < 0. 001, I2 = 78.8%). Subgroup analysis revealed the difference is also significant in a different age, surgery condition, and assay time but not acute rejection (AR) group, especially in children (SMD: - 1.21, 95% CI: - 1.80, - 0.61; P < 0.001) and patients undergoing surgery (SMD: - 1.03, 95% CI: - 1.75, - 0.30; P < 0.001). Lower uromodulin is associated with higher odds for AKI incidence (odds ratio = 2.47, 95% CI: 1.12, 5.47; P < 0.001, I2 = 89%). Meta-reggression found that age was associated with the SMD of uUMOD. The study outcome was reliably confirmed by the sensitivity analysis.
CONCLUSION: The present study suggested a negative association between uUMOD and AKI especially in children and surgical patients.
参考来源
- You R, Zheng H, Xu L, et al. Decreased urinary uromodulin is potentially associated with acute kidney injury: a systematic review and meta-analysis. J Intensive Care. 2021. PMID: 34782019. doi:10.1186/s40560-021-00584-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。